[go: up one dir, main page]

AU3246100A - Methods and compositions for inhibiting neoplastic cell growth - Google Patents

Methods and compositions for inhibiting neoplastic cell growth

Info

Publication number
AU3246100A
AU3246100A AU32461/00A AU3246100A AU3246100A AU 3246100 A AU3246100 A AU 3246100A AU 32461/00 A AU32461/00 A AU 32461/00A AU 3246100 A AU3246100 A AU 3246100A AU 3246100 A AU3246100 A AU 3246100A
Authority
AU
Australia
Prior art keywords
compositions
methods
cell growth
neoplastic cell
inhibiting neoplastic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32461/00A
Inventor
Avi J. Ashkenazi
Kenneth J. Hillan
Mary A. Napier
Colin K. Watanabe
William I. Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1999/012252 external-priority patent/WO1999063088A2/en
Priority claimed from PCT/US2000/000219 external-priority patent/WO2000053753A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU3246100A publication Critical patent/AU3246100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU32461/00A 1999-06-02 2000-02-24 Methods and compositions for inhibiting neoplastic cell growth Abandoned AU3246100A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PCT/US1999/012252 WO1999063088A2 (en) 1998-06-02 1999-06-02 Membrane-bound proteins and nucleic acids encoding the same
WOUS9912252 1999-06-02
US14569899P 1999-07-26 1999-07-26
US60145698 1999-07-26
PCT/US2000/000219 WO2000053753A2 (en) 1999-03-08 2000-01-05 Promotion or inhibition of angiogenesis and cardiovascularization
WOUS0000219 2000-01-05
PCT/US2000/004914 WO2000075327A1 (en) 1999-06-02 2000-02-24 Methods and compositions for inhibiting neoplastic cell growth

Publications (1)

Publication Number Publication Date
AU3246100A true AU3246100A (en) 2000-12-28

Family

ID=56289996

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32461/00A Abandoned AU3246100A (en) 1999-06-02 2000-02-24 Methods and compositions for inhibiting neoplastic cell growth

Country Status (2)

Country Link
AU (1) AU3246100A (en)
WO (1) WO2000075327A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
US7264801B2 (en) 1998-08-11 2007-09-04 Genentech, Inc. EG-VEGF nucleic acids and polypeptides and method of use
US20020172678A1 (en) * 2000-06-23 2002-11-21 Napoleone Ferrara EG-VEGF nucleic acids and polypeptides and methods of use
AU2001249608A1 (en) * 2000-03-28 2001-10-08 Beth Israel Deaconess Medical Center Bladder cancer-specific peptides for diagnosis and therapy
EP1302542B1 (en) 2000-07-18 2007-06-13 Takeda Pharmaceutical Company Limited Novel physiologically active peptide and use thereof
MXPA03003902A (en) 2000-11-03 2004-04-02 Univ California Prokineticin polypeptides, related compositions and methods.
US20040048314A1 (en) * 2001-02-02 2004-03-11 Tetsuya Ohtaki Novel physiologically active peptide and use thereof
ATE405323T1 (en) * 2001-02-09 2008-09-15 Serono Genetics Inst Sa GSSP4 POLYNUCLEOTIDES AND POLYPEPTIDES AND THEIR USE
GB2378183A (en) * 2001-04-25 2003-02-05 Smithkline Beecham Corp Assays of the interaction between AXOR8 or AXOR52 and BV-8 ligand
WO2003029427A2 (en) * 2001-10-03 2003-04-10 University Of Rochester Human glandular kallikrein (hk2)-specific monoclonal antibodies that enhance or inhibit the enzymatic activity of hk2
DE10229379A1 (en) * 2002-06-26 2004-01-29 Schering Ag Treatment and prevention of endometrial disease, e.g. endometriosis or carcinoma, by inhibiting endocrine gland vascular endothelial growth factor, also diagnosis
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
KR101118340B1 (en) 2003-03-12 2012-04-12 제넨테크, 인크. Use of bv8 and/or eg-vegf to promote hematopoiesis
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5416192A (en) * 1990-04-03 1995-05-16 Bristol-Myers Squibb Company Epithelins: novel cysteine-rich growth modulating proteins
JP2001512013A (en) * 1997-08-01 2001-08-21 ジェンセット 5'EST of secreted protein expressed in prostate
IL139686A0 (en) * 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
WO2000075327A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
AU3652499A (en) Iol for inhibiting cell growth and reducing glare
IL140686A0 (en) Compositions and methods for inhibiting fungal growth
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU5170900A (en) Cell proliferation inhibitors
AU5994900A (en) Compounds for inhibiting diseases and preparing cells for transplantation
AU5991699A (en) Quinolizinones as integrin inhibitors
AU3246100A (en) Methods and compositions for inhibiting neoplastic cell growth
AU2001233502A1 (en) Pancreatic islet cell growth factors
AU2832399A (en) B cell inhibitors
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU3235100A (en) Prothease inhibitors
AU6094200A (en) Nor gene compositions and methods for use thereof
AU2215300A (en) Methods and compositions for inhibiting neoplastic cell growth
AU2399300A (en) Methods and compositions for inhibiting neoplastic cell growth
AU4849199A (en) Fungal growth inhibitors
AU6859500A (en) Plant gene
AU1389801A (en) Modification of plants
AU1749800A (en) Methods and compositions for inhibiting neoplastic cell growth
AU6006800A (en) Treating cells
AU5640200A (en) Gene affecting male fertility in plants
AU4328700A (en) Pseudomycin antifungal compositions and methods for their use
AU5591100A (en) Methods and compositions for inhibiting neoplastic cell growth
IL147148A0 (en) Epithelial cell growth inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase